Skip to main content Help with accessibility Skip to main navigation

Direct Oral Anticoagulants (DOACs) for the treatment and prevention of Deep Vein Thrombosis (DVT) and/or Pulmonary Embolism (PE)

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 27 - Jan - 2022
Body System:
Amber initiated
Direct Oral Anticoagulants (DOACs) for the treatment and prevention of Deep Vein Thrombosis (DVT) and/or Pulmonary Embolism (PE)

The Pan Mersey Area Prescribing Committee recommends the prescribing of Direct Oral Anticoagulants (DOACs) for the treatment and prevention of Deep Vein Thrombosis (DVT) and/or Pulmonary Embolism (PE)